Form D · Biotechnology
Watershed Medical Inc.
Bellevue, WA · CIK 0002092749
Offering snapshot reported Apr 14, 2026 · SEC filing
- Reported sold
- $300K Offering amount: $10M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Mar 31, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 14, 2026 | Initial | $300,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06c
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $15K
- Finders' fees
- $0
- Form D file number
- 021-580220
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| ICON Capital Group, LLC | 4029 |
Source: Form D, filed Apr 14, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Christopher K Insella | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
9841 Ne 15 Th Street
Bellevue, WA, 98004
Bellevue, WA, 98004